Navigate Up

News Release Search
GO
UPMC/University of Pittsburgh Schools of the Health Sciences
​
Courtney McCrimmon
Manager
Telephone: 412-623-4701 or 412-586-9773

Patients and medical professionals may call 1-800-533-UPMC (8762) for more information.
 

UPMC Media Relations

University Of Pittsburgh Cancer Institute Receives Federal Grant To Launch Unique Project To Overcome Barriers To Participation In Clinical Trials

PITTSBURGH, July 24, 2003 Secretary of Health and Human Services, Tommy Thompson, recently announced that the University of Pittsburgh Cancer Institute (UPCI) is one of six cancer centers across the United States together awarded $5.6 million for a unique public-private partnership to help overcome barriers to participation in clinical trials for cancer.

The partnership is a groundbreaking collaborative effort among the cancer centers and the National Cancer Institute (NCI), the Foundation for the National Institutes of Health and a group of pharmaceutical companies that include Aventis, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline and Novartis.

The goal of the collaboration is to design and implement new approaches to increase access to and participation in early-phase clinical trials, or research studies, in community-based settings where patients typically experience the most barriers to enrollment.

It is only through clinical trials that we have been able to make great strides in the detection and treatment of cancer, said Samuel Jacobs, M.D., principal investigator and associate director of clinical investigations at the UPMC Cancer Centers. Unfortunately, however, only a small percentage of patients participate in research studies even though they offer promising new treatments. If we are to stay on the path of finding new cures for cancer, we need to fully address those issues that keep patients from participating in trials.

According to Dr. Jacobs, fear and expense of leaving community settings to travel to larger academic centers where most trials are conducted is a major factor that contributes to patients lack of participation. In addition, poor understanding of the clinical trials process also is a major barrier to participation.

To address these concerns, Dr. Jacobs and his colleagues at UPMC Cancer Centers will use the grant to develop a community model for conducting and enhancing patient participation in early-phase clinical trials. Researchers at the Hillman Cancer Center in Pittsburgh will work closely with community oncologists at various UPMC Cancer Centers throughout the region.

We plan to develop close links between the academic medical center and various community sites and develop outreach programs whose goal will be to increase awareness, understanding and availability of early-phase clinical trials, said Dr. Jacobs.

Our vast network of UPMC Cancer Centers throughout the region puts us at an advantage to achieve the goals of this collaboration and most importantly, it gives patients being seen at community sites access to the latest advances in cancer research, added Ronald Herberman, M.D., co-principal investigator and director of UPCI and the UPMC Cancer Centers. Through this project, we look forward to creating a national model for clinical trials that can be adapted to communities across the United States.

The UPMC Cancer Centers work in tandem with UPCI to carry out its mission as a premier NCI-designated Comprehensive Cancer Center conducting groundbreaking research into the prevention, diagnosis and treatment of cancer. Approximately 25,000 newly diagnosed cancer patients are treated at more than 40 UPMC Cancer Centers across the region each year.

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, gender identity, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com